FDA-cleared genomic profiling tests to guide cancer treatment
December 25, 2017 – The American Food & Drug Administration (FDA) has approved two genetic tests to identify genetic alterations in tumors. The FoundationOne CDx (F1CDx) genomic test and the MSK-IMPACT Tumor Profiling test both can help to guide physicians in …
FDA-cleared genomic profiling tests to guide cancer treatment Read more »